Funder
National natural science foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference51 articles.
1. Kadam V, Bagde S, Karpe M, Kadam V. A Comprehensive overview on biosimilars. Curr Protein Pept Sci. 2016;17(8):756–61.
2. Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12(10):933–80.
3. Mulcahy AW, Hlavka JP, Case SR. Biosimilar cost savings in the United States: initial experience and future potential. Rand Health Q. 2018;7(4):3 (eCollection 2018 Mar).
4. Simoens S. Biosimilar medicines and cost-effectiveness. Clinicoecon Outcomes Res. 2011;3:29–36.
https://doi.org/10.2147/ceor.s12494
(Epub 2011 Feb 10).
5. FDA. Biosimilar and interchangeable products. 2018.
https://www.fda.gov/drugs/biosimilars/biosimilar-and-interchangeable-products
. Accessed 23 Oct 2017
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献